High Intensity Focused Ultrasound Market Size, Share and Global Trend By Application (Prostate Cancer, Uterine Fibroids, Neurological Disorders, Cosmetology, Others), By End User (Hospitals, Ambulatory Surgery Centres, Cancer Treatment Centers, Physiotherapy Centers, Others), and Regional Forecast, 2024-2032

High intensity focused ultrasound (HIFU) is a non-invasive technique which is used for killing the cancer cells and tissues using high-frequency sound waves or intense heat. High intensity focused ultrasound concentrates high-intensity beams on the tumor cells that are to be destroyed, and it is utilized in the treatment of desmoids tumors, uterine fibroids, prostate cancer, and bone metastasis.

Along with cancer and neurological applications, high intensity focused ultrasound is used in cosmetology. High intensity focused ultrasound offers benefits in cosmetology such as reduction of wrinkles, skin tightening, improved jawline, double chin reduction, and improved skin elasticity. According to the American Cancer Society, out of all cancers, pancreatic cancer is responsible for an estimated 7.0% deaths in the U.S. each year, thus increasing the demand for high intensity focused ultrasound therapy.

Rising prevalence of cancer, neurological disorders, and glaucoma is a significant factor for the growth of global high intensity focused ultrasound market. Combined with this, added benefits of high intensity focused ultrasound such as minimal invasion surgery, decreased the risk of impotence, minimal procedural time, as well as minimal side effects, and faster recovery is driving the growth of global high intensity focused ultrasound market.

However, certain chances of risks such as abdominal pain, cramps, or patient discomfort are restraining factors for the growth of global high intensity focused ultrasound market.

Key Players Covered

Some of the major players present in the global high intensity focused ultrasound market are GENERAL ELECTRIC COMPANY, Koninklijke Philips N.V., Hitachi, Ltd., Ultrasound Technologies Ltd., Johnson & Johnson Services, Inc., SonaCare Medical, LLC., EpiSonica Corporation, Profound Medical Corp., EDAP TMS, ALPINION MEDICAL SYSTEMS Co., Ltd., Chongqing Haifu Medical Technology Co., Ltd., and others.

SEGMENTATION

Among the segmentation, prostate cancer in the application segment is holding a larger share owing to increasing incidence of cancer rates due to a sedentary lifestyle, unhealthy diet, etc. Uterine fibrosis is also anticipated to show higher growth during the forecast period.

Key Insights

• Overview of technological advancements in high intensity focused ultrasound market
• Regulatory challenges faced by surgeons, research institutes and companies
• Key mergers and acquisitions

Regional Analysis

Geographically the global high intensity focused ultrasound market is segmented into North America, Europe, Asia Pacific, Latin America and the Middle East and Africa. North America dominated the global high intensity focused ultrasound market in 2017 owing to rising prevalence of cancer cases such as prostate cancer, breast cancer, lung cancer, and neurological disorders. According to the American Cancer Society, breast cancer caused an estimated 40,610 deaths in the U.S. in 2017. Certain advantages offered by high intensity focused beam such as advanced safety, minimal hospital stay, faster recovery and better accuracy are boosting the demand for global high intensity focused ultrasound market in North America. Asia Pacific is also expected to show significant growth during the forecast period owing to government support for R&D and increasing incidence of cancer.

Key Industry Developments

• In October 2018, The Baldan Group, a wellness company, launched HIFU Lab system that focuses on face and body shape concerns.
• In April 2016, Venn Healthcare launched ULTRAFORMER II and III – a multi-functional high intensity focused ultrasound device that focuses on treatment of neck and face by stimulating collagen synthesis and regeneration resulting in lifting and tightening.